Neurontin: Doctors need to be Warned - The ABCs A.Illegal Marketing for off label use was successful B.8 million (at least) off label scripts – 2007 C.Off.

Slides:



Advertisements
Similar presentations
Other Mental Health Issues that Impact Learning
Advertisements

1 Off-Label Use of Medications in Workers Compensation Matthew Foster, PharmD, BCPS PMSI Clinical Services.
5th Annual PBM Pharmacy Informatics Conference
“EWE” Kick Off Meeting in November 2013 SANTA COLOMA DE GRAMENET (SPAIN)1 Home inside Soul Foundation.
Lessons from Neurobiology: Understanding the Overlap between Pain and Mood Disorders Rakesh Jain, MD, MPH R/D Clinical Research, Inc. Lake Jackson, Texas,
FDA Hearing : Cardiovascular Safety of ADHD Medications in Children & Adolescents M. Christopher Griffith, M.D. Clinical Assistant Professor: Emory University.
Antiepileptic Drugs and Suicidality: Background Evelyn Mentari, M.D., M.S. Clinical Safety Reviewer Division of Neurology Products/CDER Food and Drug Administration.
@ PMCQ U October 19, Agenda l What is Advertising? l Pre-Launch Activities You Can Do l PAAB pre-NOC Meeting/Review policy.
Patented Process for Beneficially Managing Mental Health (Psychotropic) Drug Usage by Plan Members HR Specialty Products & Services Catalogue Executive.
By Danny. The job of a psychiatrist medical specialty devoted to the treatment, study and prevention of mental disorder Help people with problems.
Avoidable Epilepsy Related Deaths Fiona McDonald Communications Manager.
Case reports Sadeghi Ramin, MD Nuclear Medicine Research Center, Mashhad University of Medical Sciences.
May 13, 2005 North Carolina State University Off-Label Use and Product Liability: Basic Principles David L. Baumer, Ph.D., J.D., Attorney at Law, Professor.
An overview of off-label drug use Ignoring the Label Samantha Rue.
Strengthening partnerships: A National Voluntary Health Agency’s initiatives in managed care Sarah L. Sampsel, MPH* Lisa M. Carlson, MPH, CHES* Michele.
April 8, 2005FDLI Annual Conference 1 Labeling Prescription Drugs for Physicians and Consumers (FDA Perspective) Paul J. Seligman, MD, MPH Director, Office.
Prescription Drug Abuse Sharon Hertz, M.D. Medical Officer Division of Anesthetic, Critical Care and Addiction Drug Products Food and Drug Administration.
Prescription Drug Abuse & Suicide SAVING GENERATION RX: PREVENTING PRESCRIPTION DRUG ABUSE IN EAST TENNESSEE SEPTEMBER 19 TH, 2014 SAMANTHA NADLER, B.S.
Behavioral Health Issues and Pediatric Hospitalizations Stephen R. Gillaspy, PhD 11/05/09 Reaching Out To Oklahoma III Annual Pediatric Interdisciplinary.
Missouri’s Primary Care and CMHC Health Home Initiative
FCA LIABILITY FOR OFF-LABEL MARKETING THOMAS M. GREENE Greene & Hoffman November 8, 2005 Serostim Update.
Regulation of Drug Marketing Introduction to Drug Law and Regulation FDLI Workshop April 28-29, 2003 Teaneck, New Jersey Philip Katz Crowell & Moring LLP.
Accutane FDA (Section Name - Saver’s Initials) 3/9/00 12:50 PM 1 Introduction Russell Ellison, MD Chief Medical Officer Vice President, Medical Affairs.
Danish Health and Medicines Authority  Denmark Dr. Else Smith, CEO Danish Health and Medicines Authority Meeting of the EU Chief Medical Officers, Chief.
Mental Health Services and Long Term Care
Tromso Telemedicine and eHealth ConferenceJune 2007 Care in the Home: What the Elderly Expect David Garwood, Secretary Patient and Citizen Task Force.
Working with the County of San Diego to Provide Mental Health Services Family Health Centers of San Diego October 31, 2007.
Opioid Risk Management Programs Celia Jaffe Winchell, M.D. Acting Deputy Division Director Division of Anesthetic, Critical Care, and Addiction Drug Products.
Depression and Parkinson Disease: An Old Drug Still Works (Better) Summary and Comment by Jonathan Silver, MD Published in Journal Watch Psychiatry February.
Treating Chronic Pain in Adolescents Amanda Bye, PsyD, Behavioral Medicine Specialist Collaborative Family Healthcare Association 15 th Annual Conference.
| > Alzheimer’s disease is fast becoming one the greatest medial challenges facing American’s today  6 th leading cause.
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
ACT in an Inpatient Hospital Setting - Get to know us! -
Behavioral Health Consultation Services - Pediatric a program to Support Behavioral Healthcare Practice in Pediatric Primary Care SmartCare.
+ Role of Industry in Clinical Care, Research, and Education.
This study has been supported by Psychotherapy for traumatised refugees – a randomised clinical trial Jessica Carlsson, M.D., PhD Charlotte Sonne, M.D.,PhD-student.
Depression Care Management Lessons from Project IMPACT _____________________________________________________ Jürgen Unützer, MD, MPH Professor and Vice.
METHODS Articles used included children and adolescents ranging in age from infancy to 18 years of age who met the Diagnostic and Statistical Manual of.
Ph: Disclaimer: Information on this page is not a substitute for medical consultation.
Professionalism in Psychiatry Kiarash Aramesh M.D. Medical Ethics and History of Medicine Research Center Tehran University of Medical Sciences.
The Physician - Pharma Relationship.  Is very old and very close  But are the goals of pharmaceutical companies and medicine the same?
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
An Analysis of Age and Gender Influences on the Relative Risk for Suicide & Psychotropic Drug Self- Poisoning AH Dawson 1, NA Buckley 2, IM Whyte 1, P.
Presenting Truthful Information to Doctors Aaron S. Kesselheim, M.D., J.D. Brigham and Women ’ s Hospital Harvard School of Public Health Boston, Massachusetts.
SOONERCARE Health Homes A Strategy to build a system of care to improve health, enhance access and quality and control costs for members with SMI or SED.
Nettie Blankenstein and Henriëtte van der Horst, GPs VU University medical center, Amsterdam MU?PS CLINIC pilot.
An Orientation To Community Benefit: What Hospital Staff Need To Know.
PANIC DISORDER What is a panic disorder ? Panic disorder(PD) is to have a sudden and repeated attacks of fear that last for several minutes and physical.
World Psychiatric Association Program on Disasters Chairs: George Christodoulou Juan-Jose Lopez-Ibor.
INTEGRATING MENTAL AND BEHAVIORAL HEALTH Empowering the team to help care for complex patients Caitlin O’Neill, MS, RD and Shandra Brown Levey, PhD.
Objectives of behavioral health integration in the Family Care Center
Moving the Needle: Toward Value-Based Integrated Mental Health Services for Patients with Chronic Medical Conditions James G Baker MD MBA Associate Chair,
The Practice of Medicine requires the Licensing and Discipline of the
Off-label Promotion: Managing the Regulatory Risks
The Comprehensive Major Depressive Disorder Care Team
Dr. Muhammad Ajmal Zahid Chairman, Department of Psychiatry,
CME and Consultants Conference Roundtable
Clinical Presentation
Primum non nocere Olabisi Oshikanlu M.D., F.A.A.P
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Statement on Concerta and Methylphenidate for the June 30, 2005 Pediatric Advisory Committee The FDA has identified two possible safety concerns with.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Forensic Psychiatrist
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Rhode Island Psychiatry Resource Networks (PRN)
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Rhode Island Psychiatry Resource Networks (PRN)
Presentation transcript:

Neurontin: Doctors need to be Warned - The ABCs A.Illegal Marketing for off label use was successful B.8 million (at least) off label scripts – 2007 C.Off label use means: –More suicide risk (depression, pain, anxiety) –NO benefits except $$$

A. List of “ ‘Movers and Shakers’ in regards to the off label use of NEURONTIN” “... there have been cases of pharmacists questioning Rxs for NEURONTIN if the patient does not have epilepsy. To avoid any problems, just tell the physician to write on the Rx pad, For pain management, when he is RXing NEURONTIN.”

A. Dear Doctor Letter Pushing Neurontin for Social Phobia Dear Healthcare Professional: “Treatment of Social Phobia with gabapentin ”

A. CME used to promote off-label use Special populations (children, women, elderly) Psychiatry CME Program Chronic Pain CME Study Groups

A. Methods of Marketing Neurontin for Psychiatric Disorders  Target psychiatrists Take some of the market from benzodiazepines Seed the literature

A. Seeding the Medical Literature  Target Pain Specialists Publish in respected pubmed journal Send Reprints

B. Off Label a continuing success

WARNING NEEDED “Neurontin’s Labeling lacked adequate directions for such [off label] use”

Doctors need to know FDA SHOULD REQUIRE that Pfizer use all the methods it used to illegally market to get the truth out about risks and off label use 1.CME on Off Label uses 2.Publish Literature on the truth 3.Detailing on the truth 4.Conferences

David Egilman MD, MPH Clinical Associate Professor Brown University Providence RI Not paid for work on this project. Have served as a consultant to authors of the citizens petition and suicide patients

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.